NEW YORK, March 16, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Nuo Therapeutics, Inc. (OTCQX: AURX), a biomedical company that pioneers leading-edge biodynamic therapies for wound care, has qualified to trade on the OTCQX® Best Market. Nuo upgraded to OTCQX from the OTCQB® Venture Market.
Nuo Therapeutics begins trading today on OTCQX under the symbol "AURX." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"Trading on OTCQX will enable Nuo Therapeutics to provide a transparent trading and information experience for investors as it focuses on growing its business and delivering long-term value to shareholders," said Jason Paltrowitz, Executive Vice President of OTC Markets Group. "We welcome Nuo Therapeutics to the OTCQX market and wish the company growth and success."
"We are pleased to now be trading on OTC Markets' highest tier market, OTCQX, as we continue to focus on one of our priorities of establishing transparent trading for Nuo's shareholders," commented David Jorden, Nuo's Chief Executive and Chief Financial Officer.
Northland Capital Markets serves as Nuo Therapeutics' OTCQX Advisor, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.
Nuo Therapeutics, Inc. is a biomedical company that pioneers leading-edge biodynamic therapies for wound care. The Company's flagship product, Aurix is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-nuo-therapeutics-to-otcqx-300424458.html
SOURCE OTC Markets Group Inc.